The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats

This publication has 29 references indexed in Scilit:

• Fixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed Outpatients
  The Journal of Clinical Psychiatry, 2002
• Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials
  CNS Spectrums, 2002
• Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram
  European Neuropsychopharmacology, 2001
• 5-HT Receptor Classification and Nomenclature: Towards a Harmonization with the Human Genome
  Neuropharmacology, 1997
• Fast onset
  International Clinical Psychopharmacology, 1997
• Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists
  Trends in Neurosciences, 1996
• 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1995
• Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression
  Journal of Clinical Psychopharmacology, 1995
• The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
• Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986